Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs

Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - February 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs

  • Regulatory Rapporteur - February 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • Half page-REGRAP-ISSUE 23-1-January 2026
      Regulatory Rapporteur January 2026 – Contents
    • AdobeStock_921561253_cover
      Navigating complexity: Regulation at the interface of innovation, technology and confidence
    • AdobeStock_521699095
      A year of change for the US FDA: An update on notable pilots and programmes
  • Veterinary
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • WEARABLES_main image
      Wearable technology: The fine regulatory line between health and wellness
    • REQUEST_main image
      Navigating regulatory scrutiny: An analysis of requests for information in EU combined clinical trials
    • RISK_main image
      Reckoning with risk: Navigating MedTech innovation
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • ICH M15 image
      New ICH M15 Guideline sets harmonised framework for MIDD
    • FDA approval image
      FDA approves non-invasive device for pancreatic cancer treatment
    • DIN SPEC 91509_image
      DIN SPEC 91509: A milestone for structured, digital medical device documentation
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • Final cover image
      MedTech in transition: Regulation, risk and real-world impact
    • TOPRA RR JCA 800x533px (6.4 ratio) (002)
      RegRapPod − InConversation with Parexel
    • AdobeStock_921561253_cover
      Navigating complexity: Regulation at the interface of innovation, technology and confidence
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Symposium 2021
        • Annual lecture
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items
Medical devices

November 2025 – Contents: Medical devices/IVD sessions

  • No comments
 

Write to the Editor at publications@topra.org

 

Margareth Jorvid

HM5/MD1/IVD1: Programme COMBINE – Accelerating clinical trials and medical innovation in the EU

By Nathalie Boeglin

 

Ulf Schriever

MD2/IVD2: Clinical investigation with medical devices

By Charlotte Holleran

 

MD3/IVD3: A global snapshot – Non-EU regulatory updates for medical devices and IVDs

By Célia Cruz

 

Natasha Bankowski_MD4 IVD4

MD4/IVD4: Bridging the gaps – Developments in medical device and IVD regulatory harmonisation

By Erica Cypas

 

Alex Laan

IVD5: Navigating conformity assessment for IVDs – Challenges and opportunities

By Natasha Bankowski

 

Ashleigh Batchen

MD5: The evolution of the EU Medical Device Regulation

By Célia Cruz

 

Ashleigh Batchen and Steffen Luckner

IVD6: The evolution of the In Vitro Diagnostic Regulation

By Hasnaa Fatehi

 

Wolfgang Lauer, Henrik Emmert and Holly Coole_MD6

MD6: The importance of digital health – Digital Health Applications (DiGA) and Digital Mental Health Technology Project

By Steve Lee

 

Alex Laan_IVD7

IVD7: EU reference laboratories under the IVDR – One year on

By Claire McDonald

 

Felicity Ellis

MD7: Updates on Artificial Intelligence legislation and policy

By Hasnaa Fatehi

 

Antonella Lombardi and Carlos Galamba

IVD8: The hunt for evidence – An IVD perspective

By Margareth Jorvid

 

Nikhil Khadabadi__MD8

MD8: Post-market challenges for medical devices

By Rachel Drapela

 

Topics

  • Advanced therapy medicinal products (ATMPs)
  • Artificial intelligence (AI)
  • Chemistry, manufacturing and controls (CMC)
  • Clinical trial
  • COMBINE
  • Electronic product information (ePI)
  • EU general pharmaceutical legislation (GPL)
  • EU HTA Regulation
  • European Medicines Agency (EMA)
  • Medical Devices
  • No comments

More from Medical devices

  • RISK_main image
    Journal

    Reckoning with risk: Navigating MedTech innovation

    2026-02-06T08:44:00Z

    By Dr Stuart R Grant

  • RAPS EUMDR-055 (1)
    Journal

    2025 UK MDR Regulatory Conference: Meeting report

    2026-01-14T09:46:00Z

    By John Wilkinson OBE, Steve Lee and Claire McDermott

  • AdobeStock_1621279576_BCI
    Journal

    Overview of the regulatory and development landscape for brain-computer interfaces in neurodegenerative disease treatment

    2026-01-14T09:39:00Z

    By ​Zabin Younes, Maria Beatrice Panico and Tauheed Ibrahim

  • Various medical devices and equipment
    Journal

    Medical device standards update: December 2025

    2025-12-15T12:43:00Z

    By Charlotte Holleran

  • Main image for online version
    Journal

    Bringing innovation to market: Regulatory strategy for MedTech companies

    2025-12-15T12:42:00Z

    By Vishal Thakker

  • Antonella Lombardi and Carlos Galamba
    Journal

    IVD8: The hunt for evidence – An IVD perspective

    2025-11-18T10:15:00Z

    By Margareth Jorvid

Related articles

  • EC med devices news story
    Industry news

    EC proposes regulation to simplify rules on medical and in vitro diagnostic devices

    2025-12-22T12:46:00Z

    By Jack Bacon

  • WEARABLES_main image
    Journal

    Wearable technology: The fine regulatory line between health and wellness

    2026-02-06T08:45:00Z

    By Jack Bacon

  • WOMEN_main image
    Journal

    From design to diversity: Embedding women’s health into medical device innovation and regulation

    2026-02-06T08:45:00Z

    By Laura Taylor

  • PARENT_main image
    Journal

    Parenteral drug delivery systems: Driving clinical success

    2026-02-06T08:44:00Z

    By David Karvani and Susan Neadle

  • REQUEST_main image
    Journal

    Navigating regulatory scrutiny: An analysis of requests for information in EU combined clinical trials

    2026-02-06T08:44:00Z

    By Amber McNair and Vladimir Vujovic

  • Final half page cover
    Contents

    Regulatory Rapporteur February 2026 – Contents

No comments yet

You're not signed in.

Only registered users can comment on this article.

Sign in Register
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud